Explore All Access
Check if your research matches the topics covered in Cancer Research and Treatment?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Research and Treatment : Impact Factor & More
eISSN: 2005-9256pISSN: 1598-2998
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Research and Treatment Key Metrics
CiteScore 
8.7
Eigenfactor
0.005 - 0.01
H-Index
52
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.72
Topics Covered on Cancer Research and Treatment
Cancer
Lung cancer
Assay
Progression-free survival
Multivariate analysis
Nasopharyngeal carcinoma
Breast cancer
Overall survival
Body mass index
Fusion gene
Adjuvant
Irradiation
Toxicity
Quality of life
Colorectal cancer
Hepatocellular carcinoma
Capmatinib
Particle therapy
Hazard ratio
Cohort study
Cancer Research and Treatment Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KOREAN CANCER ASSOCIATION |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Research and Treatment ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Research and Treatment
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
- 18 Nov 2024
- Cancer Research and Treatment
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
- 12 Nov 2024
- Cancer research and treatment
To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy.
- 11 Nov 2024
- Cancer research and treatment
Low‒Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity.
- 8 Nov 2024
- Cancer research and treatment
Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030.
- 6 Nov 2024
- Cancer research and treatment
Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma".
- 4 Nov 2024
- Cancer research and treatment
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
- 18 Nov 2024
- Cancer Research and Treatment
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
- 12 Nov 2024
- Cancer research and treatment
To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy.
- 11 Nov 2024
- Cancer research and treatment
Low‒Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity.
- 8 Nov 2024
- Cancer research and treatment
Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030.
- 6 Nov 2024
- Cancer research and treatment
Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma".
- 4 Nov 2024
- Cancer research and treatment
Compare Similar Journals with Cancer Research and Treatment
Select Journals to Compare with Cancer Research and Treatment
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Annals of Oncology
Publisher: ELSEVIER
BMC Cancer
Publisher: BMC
Cancers
Publisher: MDPI
Medicine
Publisher: Elsevier
Cancer Medicine
Publisher: WILEY
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Oncotarget
Publisher: Impact Journals
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
0 Journals Selected to compare with
Cancer Research and Treatment
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Research and Treatment
How long has Cancer Research and Treatment been actively publishing? 
Cancer Research and Treatment has been in operation since 2001 till date.
What is the publishing frequency of Cancer Research and Treatment?
Cancer Research and Treatment published with a Quarterly frequency.
How many articles did Cancer Research and Treatment publish last year?
In 2023, Cancer Research and Treatment publsihed 136 articles.
What is the eISSN & pISSN for Cancer Research and Treatment?
For Cancer Research and Treatment, eISSN is 2005-9256 and pISSN is 1598-2998.
What is Citescore for Cancer Research and Treatment?
Citescore for Cancer Research and Treatment is 8.7.
What is the H Index for Cancer Research and Treatment ?
H Index for Cancer Research and Treatment is 52.
What is SNIP score for Cancer Research and Treatment?
SNIP score for Cancer Research and Treatment is 1.72.
What is the SJR for Cancer Research and Treatment?
SJR for Cancer Research and Treatment is Q1.
Who is the publisher of Cancer Research and Treatment?
KOREAN CANCER ASSOCIATION is the publisher of Cancer Research and Treatment.
